Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586104 · ClinicalTrials.gov registry record · NA
Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
A NA study of Recurrent Adult Soft Tissue Sarcoma and Recurrent Childhood Rhabdomyosarcoma, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 7
- Study locations
NCT01586104 is a NA study of Recurrent Adult Soft Tissue Sarcoma and Recurrent Childhood Rhabdomyosarcoma that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 20 participants, below the 87-participant average among 11 other Recurrent Adult Soft Tissue Sarcoma trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT01586104, a NA study of Recurrent Adult Soft Tissue Sarcoma and Recurrent Childhood Rhabdomyosarcoma, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 7
- Study locations
Study Summary
This pilot clinical trial studies intensity-modulated radiation therapy (IMRT) in treating younger patients with lung metastases. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
Conditions Studied
Interventions
- RADIATION intensity-modulated radiation therapy
Study Locations (7)
Georgia
- Children's Healthcare of Atlanta - Egleston - Atlanta
Illinois
- Ann & Rober H Lurie Children's Hospital of Chicago - Chicago
Indiana
- Riley Hospital for Children - Indianapolis
Massachusetts
- Dana-Farber Cancer Institute - Boston
New York
- Memorial Sloan Kettering Cancer Center - New York
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-02 |
| Est. Completion | 2016-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01586104
The ClinicalTrials.gov registry entry for NCT01586104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 11 other Recurrent Adult Soft Tissue Sarcoma trials with a reported enrollment target (77% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Recurrent Adult Soft Tissue Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which intensity-modulated radiation therapy is the first listed.
NCT01586104 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Georgia, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT01586104 about?
NCT01586104 is a clinical study titled "Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases". This pilot clinical trial studies intensity-modulated radiation therapy (IMRT) in treating younger patients with lung metastases. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
What is the current status of trial NCT01586104?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-02. Estimated completion is 2016-06-02.
What conditions does trial NCT01586104 study?
This clinical trial studies the following conditions: Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma, Adult Rhabdomyosarcoma, Lung Metastases.
What interventions are being tested in trial NCT01586104?
The interventions under investigation include: intensity-modulated radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01586104?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01586104 being conducted?
This trial has 7 study locations across Georgia, Illinois, Indiana, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Adult Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
RECRUITING · NA
-
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
COMPLETED · Phase 2
-
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
COMPLETED · Phase 2
-
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
COMPLETED · Phase 2
-
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
COMPLETED · Phase 2
-
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
COMPLETED · Phase 2
Explore more on PlainTrial
Recurrent Adult Soft Tissue Sarcoma
All registered trials for this condition
Recurrent Childhood Rhabdomyosarcoma
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.